1 |
Albertyn CC, van Niekerk A, Duffy S, Avery VM, Strauss E, Chellan P. Investigation of bioorganometallic artemisinins as antiplasmodials. Journal of Organometallic Chemistry 2023. [DOI: 10.1016/j.jorganchem.2023.122633] [Reference Citation Analysis]
|
2 |
Yang T, Zhu M, Jiang M, Yang F, Zhang Z. Current status of iridium-based complexes against lung cancer. Front Pharmacol 2022;13:1025544. [DOI: 10.3389/fphar.2022.1025544] [Reference Citation Analysis]
|
3 |
Zhang S, Yi C, Li WW, Luo Y, Wu YZ, Ling HB. The current scenario on anticancer activity of artemisinin metal complexes, hybrids, and dimers. Arch Pharm (Weinheim) 2022;:e2200086. [PMID: 35484335 DOI: 10.1002/ardp.202200086] [Reference Citation Analysis]
|
4 |
Fang J, Song F, Wang F. The antimalarial activity of 1,2,4-trioxolane/trioxane hybrids and dimers: A review. Arch Pharm (Weinheim) 2022;:e2200077. [PMID: 35388499 DOI: 10.1002/ardp.202200077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
5 |
Jordaan L, Ndlovu MT, Mkhize S, Ngubane S, Loots L, Duffy S, Avery VM, Chellan P. Investigating the antiplasmodial activity of substituted cyclopentadienyl rhodium and iridium complexes of 2-(2-pyridyl)benzimidazole. Journal of Organometallic Chemistry 2022. [DOI: 10.1016/j.jorganchem.2022.122273] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|